Participating in 23andMe Research, A Customer’s Perspective

April 10, 2019
23andMe research participant Tony Garrett gives his perspective on why he is participating in research and his hopes for the future.
Read More

New Parkinson’s Disease Research May Offer Promise for Early Detection

March 27, 2019
New Parkinson’s disease research by scientists at 23andMe has identified more than 100 phenotypic variables related to the disease, offering a potential step forward in efforts to diagnose Parkinson’s disease...
Read More

October Insights into Parkinson’s Research

November 12, 2018
An update on recruitment for the Fox Insights Parkinson's research initiative.
Read More

An Interview with 23andMe’s Parkinson’s disease program Manager Paul Cannon

September 21, 2018
23andMe's Parkinson's research community manager, Paul Cannon shares his experience with Deep Brain Stimulation to treat his Parkinson's symptoms.
Read More

New Parkinson’s Disease Research Collaboration with the Michael J. Fox Foundation

October 30, 2017
As part of a broad collaboration with the Michael J. Fox Foundation, 23andMe is inviting participants in its Parkinson's Research community to participate in a new initiative called Fox Insights to make data broadly available to qualified researchers worldwide starting in 2018, with the goals of sparking innovation and discoveries around Parkinson’s disease.
Read More

Update on 23andMe Parkinson’s disease research

October 06, 2017
Participants in the 23andMe Parkinson’s disease research initiative have contributed a vast amount of data, that has enabled our researchers and collaborators to improve our understanding of the genetics of...
Read More

New Genetic Associations for Parkinson’s Disease Identified

September 11, 2017
Scientists at 23andMe and Genentech have identified 17 new genetic variants associated with Parkinson’s disease, almost doubling the total number of known risk variants for the condition, which gives scientists hints at potential new targets for drugs to treat the disease.
Read More

Learn More About 23andMe’s New Genetic Health Risk Reports

May 19, 2017
23andMe recently started offering customers new Genetic Health Risk reports that have received FDA authorization. Below we’ve highlighted some important features in these reports to help you get more out...
Read More

Parkinson’s Awareness Month

April 18, 2017
April is Parkinson’s Awareness Month and this year it also marks the eighth anniversary of 23andMe’s Parkinson’s Research Community, which introduced a game-changing model for science, one that leverages online...
Read More

Good News About Health Reports

April 06, 2017
The U.S. Food and Drug Administration granted 23andMe authorization to offer ten genetic health risk reports including late-onset Alzheimer’s disease, Parkinson’s disease, celiac disease, and a condition associated with harmful...
Read More